HOME >> BIOLOGY >> NEWS
NIH holds state-of-the-science conference on multivitamin/mineral supplements, May 15 - 17, 2006

WHAT:
An impartial, independent panel will be charged with reviewing the available scientific evidence on the effectiveness and safety of multivitamin/mineral (MVM) supplement use for chronic disease prevention on May 15 -- 17. The panel will issue a statement of its findings on the final day of the conference, and will hold a press conference at 2:00 p.m. on Wednesday, May 17. Convened by the Office of Medical Applications of Research (OMAR) and the Office of Dietary Supplements (ODS) of the NIH, this conference is free and open to the public and the media.

Conference speakers' presentations, open discussions, and the panel's statement will focus on these questions:

1. What are the current patterns and prevalence of the public's use of MVM supplements?
2. What is known about the dietary nutrient intake of MVM users versus non-users?
3. What is the efficacy of single vitamin/mineral supplement use in chronic disease prevention?
4. What is the efficacy of MVM in chronic disease prevention in the general population of adults?
5. What is known about the safety of MVM for the generally healthy population?
6. What are the major knowledge gaps and research opportunities regarding MVM use?

WHEN:
Monday, May 15, 2006, 8:30 a.m. -- 5:00 p.m.
Tuesday, May 16, 2006, 8:30 a.m. -- 12:00 p.m.
Wednesday, May 17, 9:00 a.m. -- 11:00 a.m.
Press Conference: Wednesday, May 17, 2006, 2:00 p.m.

WHERE:
Natcher Conference Center
NIH Main Campus -- Building 45
9000 Rockville Pike
Bethesda, Maryland 20892

Campus visitor information: http://www.nih.gov/about/visitor/index.htm

The conference will also be webcast live at http://videocast.nih.gov/.
(Reporters viewing the press conference via webcast will be able to submit questions
'"/>

Contact: Kelli Marciel
marcielk@od.nih.gov
301-496-4819
NIH/National Institutes of Health, Office of Disease Prevention
4-May-2006


Page: 1 2

Related biology news :

1. AFCYBER holds science and technology symposium
2. Insulin grown in plants relieves diabetes in mice; UCF study holds promise for humans
3. Detecting transmissibility of avian influenza virus in human households
4. New research holds promise for protecting cancer patients against infertility
5. Canadian paper innovation holds promise for improved global health safety
6. Honey bee genome holds clues to social behavior
7. Research holds promise for herpes vaccine
8. The first tree genome is published: Poplar holds promise as renewable bioenergy resource
9. Receptor holds the key to mosquito immune response
10. North Poles ancient past holds lessons for future global warming
11. New lipid molecule holds promise for gene therapy

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/5/2020)... ... , ... Regenative Labs has received approval from the Centers for Medicare & ... first Wharton’s jelly allografts to be assigned a Q code and be approved for ... Wharton’s jelly allograft product to be recognized as a 361 HCT/P by CMS regulated ...
(Date:7/18/2020)... ... July 16, 2020 , ... A study has been published ... Neoasis™ active noise control device to attenuate typical noises in a simulated neonatal ... the alarm sounds from patient monitors, ventilators and other bedside devices that would ...
(Date:7/2/2020)... ... July 01, 2020 , ... AltruBio Inc. http://www.altrubio.com ... a biologic for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD), at European ... J Martin of the Fred Hutchinson Cancer Research Center, this single-arm, open-label Phase ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... FARMS, Mich. (PRWEB) , ... August 12, 2020 ... ... Consulting Group, Inc. (EMMA International), a global leader in FDA compliance consulting ... of the nation’s fastest-growing private companies. The list represents a unique look at ...
(Date:8/3/2020)... (PRWEB) , ... August 03, 2020 , ... ... collection, today announced Jim Corrigan, President and CEO has been named one of ... broad cross-section of industry sectors, PharmaVoice 100 honorees are selected based on how ...
(Date:7/31/2020)... ... July 29, 2020 , ... R3 Stem Cell International is ... $3950. With 50 million stem cells total, patients may choose which extremities they would ... for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is ...
(Date:7/31/2020)... ... July 29, 2020 , ... ... transmitter systems that can be configured to drive Klystrons, TWTs, IOTs, and magnetrons. ... drive one or two switches in a push-pull configuration; yielding fast fall time ...
Breaking Biology Technology:
Cached News: